| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Innovation Officer
1 company
Brian Richard MacDonald last filed a Form 4 in June 2023, as Chief Innovation Officer at IRON. Brian Richard MacDonald's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Brian Richard MacDonald's trades have earned a below-average insider score of 48/100 across 3 rated trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +5.0%.
At the last filing, the largest reported position was 12,276 shares of IRON. The IRON filings lean toward selling, a net 15,124 shares.
Brian Richard MacDonald has 2 Form 4 filings on record from December 2022 to June 2023, all as Chief Innovation Officer at Disc Medicine (IRON), 2022–2023.
The 11 reported transactions were 10 open-market sales and 1 option or other derivative award.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $711K.
The only open-market sale was 15,124 shares of IRON at an average $47.02 on June 30, 2023, about $711K. Twelve months later IRON was up 2%.
Shares as reported in the last Form 4 for each company; the most recent is from June 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.